US Stocks
/
TransCode Therapeutics, Inc. Share Price
TransCode Therapeutics, Inc. Share Price

TransCode Therapeutics, Inc. Share Price

NASDAQ: RNAZ | Micro Cap
$1.95
+$0.17 (9.55%) Last updated on 10 Oct, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

TransCode Therapeutics, Inc. Stock Performance

Open
$1.80
Prev. Close
$1.78
Circuit Range
N/A
Day Range
$1.80 - $1.95
Year Range
$1.58 - $15.60
Volume
1,720
Average Traded
$1.86

TransCode Therapeutics, Inc. Share Price Today

As of 12 October 2026, TransCode Therapeutics, Inc.'s share price is $1.95. The stock opened at $1.80, compared to its previous close of $1.78. During today's trading session, TransCode Therapeutics, Inc.'s share price traded between $1.80 and $1.95, with an average price of $1.88. Over the past 52 weeks, the stock has recorded a high of $15.60 and a low of $1.58. In terms of performance, TransCode Therapeutics, Inc.'s share price has declined by 77.22% over the last six months and is down 84.42% on a year-on-year basis.

TransCode Therapeutics, Inc. Share Price Chart

$1.80$1.95
L
Show Current Price
H

TransCode Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.34M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.73
Revenue (TTM)
$0.00
Return On Equity (TTM)
167.12%
Profit Margin
N/A
Debt to Equity
-0.02
Quarterly Earnings Growth YoY
-41.36%

TransCode Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.86-$15.05-$19.51-$6.87
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-209.67%-29.63%64.79%

TransCode Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.56-$18.55-$16.79-$36.27
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-5.64%9.49%-116.02%

About TransCode Therapeutics, Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

TransCode Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.59
$1.95
+17.47%
Sep 2026
$2.10
$1.66
-41.45%
Aug 2026
$4.09
$2.83
-46.00%
Jul 2026
$6.56
$5.25
+3.35%
Jun 2026
$4.01
$5.08
-5.40%
May 2026
$7.58
$5.37
-37.27%
Apr 2026
$7.88
$8.56
+0.12%
Mar 2026
$9.65
$8.55
-13.94%
Feb 2026
$11.73
$9.94
-5.47%
Jan 2026
$7.16
$10.51
+58.16%
Dec 2025
$9.75
$6.64
-26.62%
Nov 2025
$8.92
$9.05
-27.68%

RNAZ Share Price FAQs

What is TransCode Therapeutics, Inc. share price today?

chevron-up
TransCode Therapeutics, Inc. share price today is $1.95 as on October 10, 2026 at 1:28 am IST.

What is the 52 week high and 52 week low of TransCode Therapeutics, Inc. stock?

chevron-up
The 52 week high of TransCode Therapeutics, Inc. stock is $15.60, while the 52 week low is $1.58 as of 10 Oct '26.

What is RNAZ's market capitalisation today?

chevron-up
RNAZ market capitalisation is $1.34M as of October 12, 2026, at 12:49 pm IST.

What is RNAZ's net income for the last quarter?

chevron-up
RNAZ's net income for the last quarter is -6.87B USD.

What is the 5 year returns of RNAZ?

chevron-up
The 5 year returns of RNAZ is -100.00% as on 10 Oct '26.

What is the high & low stock price of RNAZ today?

chevron-up
RNAZ stock price hit a high of $1.95 and low of $1.80 as of 10 Oct '26.

Can I buy RNAZ shares in India?

chevron-up
Yes. You can buy RNAZ in India by opening an international trading account.